Isabel Bravo‐Ferrer

445 total citations
9 papers, 317 citations indexed

About

Isabel Bravo‐Ferrer is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Isabel Bravo‐Ferrer has authored 9 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Neurology, 3 papers in Cellular and Molecular Neuroscience and 2 papers in Molecular Biology. Recurrent topics in Isabel Bravo‐Ferrer's work include Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Neuroscience and Neuropharmacology Research (2 papers) and Barrier Structure and Function Studies (1 paper). Isabel Bravo‐Ferrer is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Neuroscience and Neuropharmacology Research (2 papers) and Barrier Structure and Function Studies (1 paper). Isabel Bravo‐Ferrer collaborates with scholars based in Spain, United Kingdom and Austria. Isabel Bravo‐Ferrer's co-authors include Marı́a A. Moro, Ignacio Lizasoaín, Alicia García‐Culebras, Violeta Durán‐Laforet, María Isabel Cuartero, Jesús M. Pradillo, Juan M. García‐Segura, Carolina Peña‐Martínez, Jaime Díaz‐Guzmán and Macarena Hernández‐Jiménez and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Stroke.

In The Last Decade

Isabel Bravo‐Ferrer

9 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabel Bravo‐Ferrer Spain 6 112 94 81 63 62 9 317
Yueman Zhang China 13 188 1.7× 101 1.1× 91 1.1× 26 0.4× 53 0.9× 24 385
Birgit Fogal United States 7 106 0.9× 111 1.2× 86 1.1× 30 0.5× 105 1.7× 9 381
Víctor G. Romera Spain 8 83 0.7× 172 1.8× 25 0.3× 35 0.6× 69 1.1× 9 373
Sachi Kuwahara‐Otani Japan 11 145 1.3× 124 1.3× 42 0.5× 33 0.5× 47 0.8× 25 400
Mengna Peng China 9 195 1.7× 256 2.7× 68 0.8× 38 0.6× 47 0.8× 16 511
Georgia Fodelianaki Germany 5 111 1.0× 100 1.1× 74 0.9× 35 0.6× 54 0.9× 6 342
Harpreet Mandhair Switzerland 6 114 1.0× 96 1.0× 62 0.8× 13 0.2× 37 0.6× 11 325
Sara L. Domínguez United States 10 70 0.6× 143 1.5× 26 0.3× 27 0.4× 57 0.9× 14 337
Zhihao Mu China 11 114 1.0× 95 1.0× 29 0.4× 23 0.4× 28 0.5× 21 323
Gabriella Pál Hungary 7 147 1.3× 132 1.4× 65 0.8× 46 0.7× 57 0.9× 7 344

Countries citing papers authored by Isabel Bravo‐Ferrer

Since Specialization
Citations

This map shows the geographic impact of Isabel Bravo‐Ferrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Bravo‐Ferrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Bravo‐Ferrer more than expected).

Fields of papers citing papers by Isabel Bravo‐Ferrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Bravo‐Ferrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Bravo‐Ferrer. The network helps show where Isabel Bravo‐Ferrer may publish in the future.

Co-authorship network of co-authors of Isabel Bravo‐Ferrer

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Bravo‐Ferrer. A scholar is included among the top collaborators of Isabel Bravo‐Ferrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Bravo‐Ferrer. Isabel Bravo‐Ferrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Bravo‐Ferrer, Isabel, Katie Emelianova, Owen Dando, et al.. (2025). Molecular profiling of brain endothelial cell to astrocyte endfoot communication in mouse and human. Nature Communications. 16(1). 9750–9750. 2 indexed citations
2.
Bravo‐Ferrer, Isabel, et al.. (2025). Multiregional blood-brain barrier phenotyping identifies the prefrontal cortex as the most vulnerable region to ageing in mice. Brain Communications. 7(5). fcaf332–fcaf332. 1 indexed citations
3.
Fraga, Enrique, María Isabel Cuartero, Alicia García‐Culebras, et al.. (2023). Defective hippocampal neurogenesis underlies cognitive impairment by carotid stenosis-induced cerebral hypoperfusion in mice. Frontiers in Cellular Neuroscience. 17. 4 indexed citations
4.
Bravo‐Ferrer, Isabel, Baljit S. Khakh, & Blanca Díaz‐Castro. (2022). Cell-specific RNA purification to study translatomes of mouse central nervous system. STAR Protocols. 3(2). 101397–101397. 6 indexed citations
5.
Salobrar‐García, Elena, Inés López‐Cuenca, Rosa de Hoz, et al.. (2021). Retinal Thickness Changes Over Time in a Murine AD Model APPNL-F/NL-F. Frontiers in Aging Neuroscience. 12. 625642–625642. 18 indexed citations
6.
Cuartero, María Isabel, J. Parra, Isabel Bravo‐Ferrer, et al.. (2019). Abolition of aberrant neurogenesis ameliorates cognitive impairment after stroke in mice. Journal of Clinical Investigation. 129(4). 1536–1550. 89 indexed citations
7.
Bravo‐Ferrer, Isabel, María Isabel Cuartero, Carolina Peña‐Martínez, et al.. (2019). Lack of the aryl hydrocarbon receptor accelerates aging in mice. The FASEB Journal. 33(11). 12644–12654. 37 indexed citations
8.
Peña‐Martínez, Carolina, Violeta Durán‐Laforet, Alicia García‐Culebras, et al.. (2019). Pharmacological Modulation of Neutrophil Extracellular Traps Reverses Thrombotic Stroke tPA (Tissue-Type Plasminogen Activator) Resistance. Stroke. 50(11). 3228–3237. 107 indexed citations
9.
Bravo‐Ferrer, Isabel, María Isabel Cuartero, Juan G. Zarruk, et al.. (2016). Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke. Stroke. 48(1). 204–212. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yueman Zhang Breakdown of academic impact, for papers by Birgit Fogal Breakdown of academic impact, for papers by Víctor G. Romera Breakdown of academic impact, for papers by Sachi Kuwahara‐Otani Breakdown of academic impact, for papers by Mengna Peng Breakdown of academic impact, for papers by Georgia Fodelianaki Breakdown of academic impact, for papers by Harpreet Mandhair Breakdown of academic impact, for papers by Sara L. Domínguez Breakdown of academic impact, for papers by Zhihao Mu Breakdown of academic impact, for papers by Gabriella Pál
Rankless by CCL
2026